CN106045975A - A preparing method for high-purity ilaprazole sodium - Google Patents
A preparing method for high-purity ilaprazole sodium Download PDFInfo
- Publication number
- CN106045975A CN106045975A CN201610307666.0A CN201610307666A CN106045975A CN 106045975 A CN106045975 A CN 106045975A CN 201610307666 A CN201610307666 A CN 201610307666A CN 106045975 A CN106045975 A CN 106045975A
- Authority
- CN
- China
- Prior art keywords
- methyl
- acid
- preparation
- methoxy
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZQGDDMFDBZPGCD-UHFFFAOYSA-N sodium 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-5-pyrrol-1-ylbenzimidazol-3-ide Chemical compound [Na+].COC1=CC=NC(CS(=O)C=2[N-]C3=CC=C(C=C3N=2)N2C=CC=C2)=C1C ZQGDDMFDBZPGCD-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 239000002253 acid Substances 0.000 claims abstract description 8
- 150000007529 inorganic bases Chemical class 0.000 claims abstract description 6
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 6
- 239000011734 sodium Substances 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- 239000003125 aqueous solvent Substances 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 2
- 229940106681 chloroacetic acid Drugs 0.000 claims description 2
- 150000004693 imidazolium salts Chemical class 0.000 claims description 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 2
- 239000012043 crude product Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 8
- CDXSJGDDABYYJV-UHFFFAOYSA-N acetic acid;ethanol Chemical compound CCO.CC(O)=O CDXSJGDDABYYJV-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000007670 refining Methods 0.000 description 5
- 239000012065 filter cake Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- BHVRHDLXKLRTEY-UHFFFAOYSA-N 2-sulfinyl-1,3-dihydrobenzimidazole Chemical compound C1=CC=C2NC(=S=O)NC2=C1 BHVRHDLXKLRTEY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical group C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 2
- RBWFVUDBNNXTFZ-UHFFFAOYSA-N 1h-imidazole;potassium Chemical compound [K].C1=CNC=N1 RBWFVUDBNNXTFZ-UHFFFAOYSA-N 0.000 description 1
- YNCPXBIZAPNQIJ-UHFFFAOYSA-N 1h-imidazole;sodium Chemical compound [Na].C1=CNC=N1 YNCPXBIZAPNQIJ-UHFFFAOYSA-N 0.000 description 1
- VNQSJROWHKEIMD-UHFFFAOYSA-N 2-sulfonyl-1,3-dihydrobenzimidazole Chemical compound C1=CC=C2NC(=S(=O)=O)NC2=C1 VNQSJROWHKEIMD-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 1
- HRRXCXABAPSOCP-UHFFFAOYSA-N ilaprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC(=CC=C3N=2)N2C=CC=C2)=C1C HRRXCXABAPSOCP-UHFFFAOYSA-N 0.000 description 1
- 229950008491 ilaprazole Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明提供一种高纯度艾普拉唑钠的制备方法,包括下述步骤:1)将5‑(1H‑吡咯‑1‑基)‑2‑[[(4‑甲氧基‑3‑甲基)‑2‑吡啶基]‑甲基]‑亚磺酰基‑1H‑苯并咪唑粗品溶于有机溶剂,加入无机碱成盐,过滤,制得5‑(1H‑吡咯‑1‑基)‑2‑[[(4‑甲氧基‑3‑甲基)‑2‑吡啶基]‑甲基]‑亚磺酰基‑1H‑苯并咪唑盐(A);2)将A溶于有机溶剂、使用酸调pH至弱碱性,制得高纯度5‑(1H‑吡咯‑1‑基)‑2‑[[(4‑甲氧基‑3‑甲基)‑2‑吡啶基]‑甲基]‑亚磺酰基‑1H‑苯并咪唑(B);3)将制得的B与含钠化合物在含水溶剂中反应,制备得到艾普拉唑钠。The invention provides a kind of preparation method of high-purity ilaprazole sodium, comprising the following steps: 1) 5-(1H-pyrrole-1-yl)-2-[[(4-methoxy-3-methyl Base)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole crude product is dissolved in an organic solvent, added an inorganic base to form a salt, and filtered to obtain 5-(1H-pyrrole-1-yl)- 2‑[[(4‑methoxy‑3‑methyl)‑2‑pyridyl]‑methyl]‑sulfinyl‑1H‑benzimidazolium salt (A); 2) A is dissolved in an organic solvent, Use acid to adjust the pH to weak alkaline to prepare high-purity 5-(1H-pyrrole-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl ]-sulfinyl-1H-benzimidazole (B); 3) reacting the prepared B with a sodium-containing compound in an aqueous solvent to prepare ilaprazole sodium.
Description
技术领域technical field
本发明涉及药物制备领域,具体涉及艾普拉唑钠的精制方法。The invention relates to the field of medicine preparation, in particular to a method for refining ilaprazole sodium.
背景技术Background technique
在中国专利CN94191913.7中描述了5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑的合成方法,该合成方法以氯仿为溶剂,间氯过氧苯甲酸为氧化剂氧化5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-巯基-1H-苯并咪唑制备5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑。合成路线如下:5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinic acid is described in Chinese patent CN94191913.7 The synthetic method of acyl-1H-benzimidazole, the synthetic method uses chloroform as a solvent, m-chloroperoxybenzoic acid as an oxidizing agent to oxidize 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy -3-methyl)-2-pyridyl]-methyl]-mercapto-1H-benzimidazole to prepare 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3- Methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole. The synthetic route is as follows:
然而,该路线在氧化过程中间容易发生过氧化的副反应,导致生成过氧化磺酰化物难以除去。目前的技术中,并没有能有效去除杂质、得到高纯度艾普拉唑钠盐的制备方法。However, this route is prone to peroxidative side reactions in the middle of the oxidation process, resulting in the formation of peroxysulfonyl compounds that are difficult to remove. In the current technology, there is no preparation method that can effectively remove impurities and obtain high-purity ilaprazole sodium salt.
发明内容Contents of the invention
本发明提供的是一种高收率、反应条件易操控,并且环保的精制5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钠(艾普拉唑钠)的方法。The present invention provides a refined 5-(1H-pyrrol-1-yl)-2-[[(4-methoxyl-3-methyl)-2 -pyridyl]-methyl]-sulfinyl-1H-benzimidazole sodium (ilaprazole sodium) method.
为实现以上目的,本发明采用以下技术方案,包括步骤:To achieve the above object, the present invention adopts the following technical solutions, including steps:
(1)将5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑粗品溶于有机溶剂A,加入无机碱成盐,过滤,制得5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑盐;(1) 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzene The crude imidazole was dissolved in organic solvent A, added with inorganic base to form a salt, and filtered to obtain 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2- Pyridyl]-methyl]-sulfinyl-1H-benzimidazolium salt;
(2)将5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑盐溶于有机溶剂B、使用pH调节剂酸调pH至弱碱性,制得高纯度5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑;(2) 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzene Dissolve imidazolium salt in organic solvent B, adjust the pH to weak alkalinity with pH regulator acid, and obtain high-purity 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3- Methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole;
(3)将制得的高纯度5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑与含钠化合物,在含水溶剂中反应,制备得到艾普拉唑钠。(3) The obtained high-purity 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinic acid Acyl-1H-benzimidazole reacts with a sodium-containing compound in an aqueous solvent to prepare ilaprazole sodium.
具体合成路线如下:Concrete synthetic route is as follows:
上述步骤(1)中所使用的有机溶剂A包括甲醇,乙醇,异丙醇,二甲苯,甲苯,四氢呋喃,1,2-二氯乙烷,丙酮,乙醚,二氯甲烷,乙腈,二甲亚砜,N,N-二甲基乙酰胺中的一种或多种。优先选用甲醇,乙醇。The organic solvent A used in the above-mentioned step (1) comprises methyl alcohol, ethanol, Virahol, xylene, toluene, tetrahydrofuran, 1,2-dichloroethane, acetone, ether, dichloromethane, acetonitrile, dimethyl ethylene One or more of sulfone and N,N-dimethylacetamide. Methanol and ethanol are preferred.
上述步骤(1)中反应温度范围为0-100℃。优先选用室温25℃。The reaction temperature range in the above step (1) is 0-100°C. The room temperature of 25°C is preferred.
上述步骤(1)中所用无机碱包括氢氧化钠、氢氧化钾、氢氧化锂一种或多种。优先选用氢氧化钠、氢氧化钾。The inorganic base used in the above step (1) includes one or more of sodium hydroxide, potassium hydroxide and lithium hydroxide. Sodium hydroxide and potassium hydroxide are preferred.
上述步骤(2)中所使用的有机溶剂B包括甲醇,乙醇,异丙醇,二甲苯,甲苯,四氢呋喃,1,2-二氯乙烷,丙酮,乙醚,二氯甲烷,乙腈,二甲亚砜,N,N-二甲基乙酰胺中的一种或多种。优先选用乙醇。The organic solvent B used in the above-mentioned step (2) comprises methyl alcohol, ethanol, Virahol, xylene, toluene, THF, 1,2-dichloroethane, acetone, ether, dichloromethane, acetonitrile, dimethyl ethylene One or more of sulfone and N,N-dimethylacetamide. Ethanol is preferred.
上述步骤(2)中反应温度范围为0-100℃。优先选用25℃。The reaction temperature range in the above step (2) is 0-100°C. 25°C is preferred.
上述步骤(2)中调节pH至7.5-9.5,最优为9.0;pH调节剂的酸可用苯甲酸、盐酸、硫酸、磷酸、硝酸、醋酸、氯乙酸、异辛酸、丁酸、甲基磺酸中的一种或多种,优先选用醋酸乙醇溶液。在本反应中,pH的调节与调节速率十分重要,调酸后的pH值过高会导致有部分艾普拉唑钠盐析出,降低产品产率;而pH值过低会导致降解产物生成,形成杂质。醋酸与其他酸相比,在调节pH值得过程中间不会产生因局部pH值过低而破坏艾普拉唑。Adjust pH to 7.5-9.5 in the above-mentioned step (2), optimally is 9.0; The acid of pH adjuster can be benzoic acid, hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, acetic acid, chloroacetic acid, isooctanoic acid, butyric acid, methanesulfonic acid One or more of them, preferably acetic acid ethanol solution. In this reaction, the adjustment and adjustment rate of pH are very important. If the pH value after acid adjustment is too high, some ilaprazole sodium salts will be precipitated and the product yield will be reduced; and if the pH value is too low, degradation products will be generated. Impurities are formed. Compared with other acids, acetic acid will not destroy ilaprazole due to low local pH value during the process of pH adjustment.
本发明的精制方法可以有效的除去副反应产生的过氧化磺酰化物,使制得的5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑的产品纯度高;精制工艺简单易行,收率高;环保,对环境无污染。The refining method of the present invention can effectively remove the peroxysulfonyl compound produced by the side reaction, so that the prepared 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl )-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole has high product purity; the refining process is simple and easy, and the yield is high; it is environmentally friendly and has no pollution to the environment.
具体而言,本发明专利具有以下优势:Specifically, the invention patent has the following advantages:
1、产品质量高。产品纯度大于99.5%,可以有效去除5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑制备过程中间产生的5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-磺酰基-1H-苯并咪唑以及其他杂质。1. High product quality. The purity of the product is greater than 99.5%, which can effectively remove 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinic acid 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl] produced during the preparation of acyl-1H-benzimidazole -Sulfonyl-1H-benzimidazole and other impurities.
2、反应条件温和,操作简单。在精制工艺中,反应所需温度为室温,工艺操作简单。2. The reaction conditions are mild and the operation is simple. In the refining process, the temperature required for the reaction is room temperature, and the process operation is simple.
3、绿色环保。精制过程没有使用毒性大的试剂,使用的试剂对环境污染小,易于处理。3. Green and environmental protection. The refining process does not use highly toxic reagents, and the reagents used have little environmental pollution and are easy to handle.
因此,本发明专利可以有效的提高5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑的质量,具有实际应用意义。Therefore, the patent of the present invention can effectively improve 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinic acid The quality of acyl-1H-benzimidazole has practical application significance.
具体实施例specific embodiment
实施例1:5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钾盐的制备Example 1: 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzene Preparation of imidazole potassium salt
250mL的三口烧瓶中加入甲醇(110mL),氢氧化钾(3.1g),搅拌溶解澄清,之后加入5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑(20g),将混合物在25℃下搅拌18小时。将混合物过滤,滤饼用甲醇(20mL*2)洗涤,收集固体在40℃下干燥4小时,得5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钾盐(20.0g),收率:90%。Add methanol (110mL) and potassium hydroxide (3.1g) to a 250mL three-necked flask, stir to dissolve and clarify, then add 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3- Methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole (20 g), and the mixture was stirred at 25° C. for 18 hours. The mixture was filtered, the filter cake was washed with methanol (20mL*2), and the collected solid was dried at 40°C for 4 hours to obtain 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3 -Methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole potassium salt (20.0 g), yield: 90%.
实施例2:5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钠盐的制备Example 2: 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzene Preparation of imidazole sodium salt
250mL的三口烧瓶中加入有机溶剂A(110mL),氢氧化钠(2.2g),搅拌溶解澄清,之后加入5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑(20g),将混合物在特定温度下搅拌18小时。将混合物过滤,滤饼用甲醇(20mL*2)洗涤,收集固体在40℃下干燥4小时,得5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钠盐,具体如表1所示:Add organic solvent A (110mL) and sodium hydroxide (2.2g) to a 250mL three-necked flask, stir to dissolve and clarify, then add 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy- 3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole (20 g), and the mixture was stirred at a specific temperature for 18 hours. The mixture was filtered, the filter cake was washed with methanol (20mL*2), and the collected solid was dried at 40°C for 4 hours to obtain 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3 -methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzimidazole sodium salt, specifically as shown in Table 1:
表1:有机溶剂A、反应温度实验结果比较Table 1: Comparison of experimental results of organic solvent A and reaction temperature
如上表所示,有机溶剂A优选甲醇、乙醇,反应温度优选25℃。As shown in the table above, the organic solvent A is preferably methanol or ethanol, and the reaction temperature is preferably 25°C.
实施例3:5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑的制备Example 3: 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzene Preparation of imidazole
在500mL的三口烧瓶中加入乙醇(200mL),5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钾盐(10g),25℃下滴加10%醋酸乙醇溶液调节pH值到9.0,静置30分钟后过滤,滤饼用乙醇水溶液(50%,30mL*2)洗涤,之后在30℃下烘干的5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑(7.4g,白色固体),收率:82%,纯度为99.2%。Add ethanol (200mL) to a 500mL three-necked flask, 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl] -Sulfinyl-1H-benzimidazole potassium salt (10g), add 10% acetic acid ethanol solution dropwise at 25°C to adjust the pH value to 9.0, let stand for 30 minutes and filter, filter cake with ethanol aqueous solution (50%, 30mL* 2) 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl] after washing and drying at 30°C -Sulfinyl-1H-benzimidazole (7.4 g, white solid), yield: 82%, purity: 99.2%.
实施例4:5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑的制备Example 4: 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-sulfinyl-1H-benzene Preparation of imidazole
在500mL的三口烧瓶中加入有机溶剂B(200mL),5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钾盐(10g),25℃下滴加pH调节剂,调节pH值到9.0,静置30分钟后过滤,滤饼用乙醇水溶液(50%,30mL*2)洗涤,之后在30℃下烘干的5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑,具体如表2所示:In a 500mL three-necked flask, organic solvent B (200mL), 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl Base]-sulfinyl-1H-benzimidazole potassium salt (10g), drop a pH regulator at 25°C, adjust the pH value to 9.0, filter after standing for 30 minutes, filter cake with ethanol aqueous solution (50%, 30mL *2) 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl after washing and drying at 30°C ]-sulfinyl-1H-benzimidazole, specifically as shown in Table 2:
表2:有机溶剂B、pH调节剂实验结果比较Table 2: Comparison of experimental results of organic solvent B and pH regulator
如上表所示,有机溶剂B优选乙醇,pH调节剂优选醋酸乙醇溶液。As shown in the table above, the organic solvent B is preferably ethanol, and the pH regulator is preferably acetic acid ethanol solution.
实施例5:pH调节对实验结果的影响Embodiment 5: the influence of pH regulation on experimental result
在500mL的三口烧瓶中加入乙醇(200mL),5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑钠盐(10g),室温下滴加10%醋酸乙醇溶液调节pH值,之后静置30分钟后过滤,滤饼用乙醇水溶液(50%,30mL*2)洗涤,之后在30℃下烘干的5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑(7.3g,白色固体),具体如表3所示:Add ethanol (200mL) to a 500mL three-necked flask, 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl] -Sulphinyl-1H-benzimidazole sodium salt (10g), add 10% acetic acid ethanol solution dropwise at room temperature to adjust the pH value, then let it stand for 30 minutes and filter, and filter the cake with ethanol aqueous solution (50%, 30mL*2) After washing, the 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]-ylidene Sulfonyl-1H-benzimidazole (7.3g, white solid), specifically as shown in Table 3:
表3:调节后pH值与实验结果的比较Table 3: Comparison of adjusted pH value and experimental results
结论:由上表的结果可以看出,当调节后的pH低至6.5时,产品产率及产品纯度都偏低;当调节后的pH高至10.5时,产品的收率当大幅度下降。而调节后的pH在7.5-9.5时,产品的收率与产品的纯度都在较优的范围内,符合生产要求。Conclusion: From the results in the table above, it can be seen that when the adjusted pH is as low as 6.5, the product yield and product purity are low; when the adjusted pH is as high as 10.5, the product yield should drop significantly. And when the pH after adjustment is 7.5-9.5, the yield of the product and the purity of the product are all in a better range, meeting the production requirements.
实施例6 艾普拉唑钠盐的制备Embodiment 6 Preparation of ilaprazole sodium salt
取上述实施例4所制备得到的产物:5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑10.0g(0.0273mol),加入50ml甲醇中,加入氢氧化钠1.09g(0.0273mol),室温搅拌2小时,浓缩,加入正丁醇,加入异丙醚室温结晶,所得产品于60℃减压干燥得白色结晶,即艾普拉唑钠9.5g,收率:90%,含量:99.8%。Take the product prepared in the above-mentioned Example 4: 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]- Add 10.0g (0.0273mol) of sulfinyl-1H-benzimidazole to 50ml of methanol, add 1.09g (0.0273mol) of sodium hydroxide, stir at room temperature for 2 hours, concentrate, add n-butanol, add isopropyl ether to crystallize at room temperature , the obtained product was dried under reduced pressure at 60° C. to obtain white crystals, i.e. ilaprazole sodium 9.5 g, yield: 90%, content: 99.8%.
实施例7 艾普拉唑钠盐的制备Example 7 Preparation of ilaprazole sodium salt
取上述实施例5所制备得到的产物:5-(1H-吡咯-1-基)-2-[[(4-甲氧基-3-甲基)-2-吡啶基]-甲基]-亚磺酰基-1H-苯并咪唑10.0g(0.0273mol),加入50ml甲醇中,升温至50℃,加入包含30%(重量)甲醇钠的甲醇溶液4.92g(0.0273mol),搅拌2小时,冷却至0℃,过滤,所得产品于60℃减压干燥得白色结晶,即艾普拉唑钠9.33g,收率:88%,含量:99.9%。Take the product prepared in Example 5 above: 5-(1H-pyrrol-1-yl)-2-[[(4-methoxy-3-methyl)-2-pyridyl]-methyl]- Add 10.0 g (0.0273 mol) of sulfinyl-1H-benzimidazole to 50 ml of methanol, heat up to 50 ° C, add 4.92 g (0.0273 mol) of methanol solution containing 30% (weight) sodium methoxide, stir for 2 hours, and cool to 0°C, filtered, and the obtained product was dried under reduced pressure at 60°C to obtain white crystals, i.e. ilaprazole sodium 9.33g, yield: 88%, content: 99.9%.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610307666.0A CN106045975A (en) | 2016-05-05 | 2016-05-05 | A preparing method for high-purity ilaprazole sodium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610307666.0A CN106045975A (en) | 2016-05-05 | 2016-05-05 | A preparing method for high-purity ilaprazole sodium |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106045975A true CN106045975A (en) | 2016-10-26 |
Family
ID=57176240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610307666.0A Pending CN106045975A (en) | 2016-05-05 | 2016-05-05 | A preparing method for high-purity ilaprazole sodium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106045975A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749191A (en) * | 2016-12-10 | 2017-05-31 | 珠海保税区丽珠合成制药有限公司 | Ilaprazole crystal form II and preparation method thereof |
CN110128412A (en) * | 2019-06-21 | 2019-08-16 | 丽珠医药集团股份有限公司 | The preparation method of dextrorotation Iprazole sylvite mother liquor, dextrorotation Iprazole and preparation method thereof |
CN111187255A (en) * | 2020-01-13 | 2020-05-22 | 丽珠医药集团股份有限公司 | Preparation method of dextro-ilaprazole potassium salt and preparation method of dextro-ilaprazole |
-
2016
- 2016-05-05 CN CN201610307666.0A patent/CN106045975A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749191A (en) * | 2016-12-10 | 2017-05-31 | 珠海保税区丽珠合成制药有限公司 | Ilaprazole crystal form II and preparation method thereof |
CN110128412A (en) * | 2019-06-21 | 2019-08-16 | 丽珠医药集团股份有限公司 | The preparation method of dextrorotation Iprazole sylvite mother liquor, dextrorotation Iprazole and preparation method thereof |
CN110128412B (en) * | 2019-06-21 | 2020-03-31 | 丽珠医药集团股份有限公司 | Preparation method of dextro-ilaprazole potassium salt mother liquor, dextro-ilaprazole and preparation method thereof |
CN111187255A (en) * | 2020-01-13 | 2020-05-22 | 丽珠医药集团股份有限公司 | Preparation method of dextro-ilaprazole potassium salt and preparation method of dextro-ilaprazole |
CN111187255B (en) * | 2020-01-13 | 2021-07-20 | 丽珠医药集团股份有限公司 | Preparation method of dextro-ilaprazole potassium salt and preparation method of dextro-ilaprazole |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106045975A (en) | A preparing method for high-purity ilaprazole sodium | |
CN105001169B (en) | A kind of synthetic method of 3 aminoquinoxaline 2 (1H) ketone compounds | |
CN107382803A (en) | A kind of preparation method of β hydroxy phenyls selenide compound | |
CN107663209A (en) | 2 phenyl 3 (benzenesulfonyl) imidazo [1,2 a] pyridine compounds and theirs and its synthetic method | |
CN107915586A (en) | A kind of oxybenzene compound and preparation method | |
CN114957236A (en) | Preparation method of 2-acylaminothiazole compound | |
CN102086169A (en) | Preparation method of intermediates of Febuxostat | |
CN116514835A (en) | Organic photoelectric compound, preparation method and application thereof | |
CN106032358A (en) | A kind of synthetic technique of sulfasalazine | |
CN103524489A (en) | Synthesis process of 2-chlorin-5-((2-(nitryl methylene) imidazoline-1-yl) methyl) pyridine | |
CN106045978A (en) | Synthesizing method of llaprazole sodium | |
CN103408507A (en) | Preparation method for 2-amino-1,3,4-thiadiazole compounds | |
CN103923086B (en) | A kind of preparation method of 5-alkoxyl-1,2,4-triazole [4,3-c] pyrimidine-3 (2H)-thioketone | |
CN103044399B (en) | Preparation method of rabeprazole and sodium salts thereof | |
CN103214430B (en) | Method for preparing 3-acetyl-10-alkyl phenothiazine | |
CN104130190B (en) | A kind of synthetic method of pyrazole derivatives | |
CN102659550A (en) | Method for producing acetylacetone beryllium | |
CN105949108B (en) | A kind of 3- (4- Methoxv-phenylsulfanvls) -1- methyl -- the preparation method of 1H- pyrrole-2,5-diones compounds | |
CN104230785B (en) | The synthetic method of 3-((4-chlorphenyl) sulfo-) the bromo-1-hydrogen-indole of-5- | |
CN105153421B (en) | One kind prepares tetramethyl piperidine nitrogen oxygen free radical polymer process | |
CN102626655B (en) | Aldol reaction catalyst and preparation method and application thereof | |
CN114213389B (en) | Synthesis method of benzo [ b ] naphtho [2,3-d ] thiophene | |
CN109369500B (en) | Separation method of 3-indolebutyric acid and 1-indolebutyric acid | |
CN104530003A (en) | Preparation method of salt of pyridylmethylsulfinyl-1H-benzimidazole compound | |
CN108530344B (en) | A kind of aromatic diamine containing terpyridine structure and its synthesis method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161026 |
|
RJ01 | Rejection of invention patent application after publication |